Short Communication
|
Open Access
Featured
-
-
Genetics and Genomics
| Open AccessFocal amplification of the androgen receptor gene in hormone-naive human prostate cancer
- S Merson
- , Z H Yang
- & J P Clark
-
Molecular Diagnostics
| Open AccessFGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study
- X Su
- , P Zhan
- & E Kilgour
-
Genetics and Genomics
| Open AccessKRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer
- E Birkeland
- , E Wik
- & H B Salvesen
-
Clinical Study
| Open AccessMulticentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer
- J Harder
- , G Ihorst
- & M Geissler
-
Molecular Diagnostics
| Open AccessFGFR2 gene amplification and clinicopathological features in gastric cancer
- K Matsumoto
- , T Arao
- & Y Yamada
-
Molecular Diagnostics
| Open AccessDifferential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification
- J Tanizaki
- , I Okamoto
- & K Nakagawa
-
Molecular Diagnostics
| Open AccessImproving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer
- L M Flores
- , D W Kindelberger
- & I E Krop
-
Molecular Diagnostics
| Open AccessPrediction of CCND1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinoma
- H Takeshita
- , D Ichikawa
- & E Otsuji